Search results for "mutation."

showing 10 items of 2808 documents

Birt–Hogg–Dubé Syndrome: An Update

2012

Birt-Hogg-Dube syndrome is a rare autosomal dominant genodermatosis that is characterized by the presence of fibrofolliculomas and/or trichodiscomas, pulmonary cysts, spontaneous pneumothorax, and renal tumors. The most common histological types found in renal tumors from patients with the syndrome are oncocytoma-chromophobe carcinoma hybrids and pure forms of chromophobe carcinoma, oncocytic carcinoma, and clear cell or papillary cell carcinoma. The syndrome is linked to mutations in the FLCN gene, which encodes folliculin and is preferentially expressed in the skin, kidney, and lung. The syndrome can exhibit a high degree of clinical variability, and the skin lesions that are a warning si…

Pathologymedicine.medical_specialtyHistologyAdenomabusiness.industryGenodermatosisDermatologymedicine.diseaseBirt–Hogg–Dubé syndromePathology and Forensic MedicineGermline mutationPneumothoraxCarcinomaMedicineFolliculinbusinessClear cellActas Dermo-Sifiliográficas (English Edition)
researchProduct

Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with…

1995

Mutations of the p53 gene often result in the overexpression of p53 protein. Previous studies have suggested that the function of p53 and its mutant protein forms may be linked with the disease course of patients with a breast carcinoma. In the present study, we tested 462 primary breast carcinomas for the presence of p53 antigen using immunohistochemical methods employing antibodies against the clone, DO-1. These tumors were also immunohistochemically stained using the monoclonal antibody, MIB-1, in order to demonstrate the presence of Ki67. Comparison of the presence of p53 with other prognostic parameters revealed highly significant negative correlations with estrogen- and progesterone-r…

Pathologymedicine.medical_specialtyMammary glandBreast NeoplasmsDisease-Free SurvivalAntigenmedicineCarcinomaBiomarkers TumorHumansProliferation MarkerCell NucleusEpitheliomabiologybusiness.industryObstetrics and GynecologyAntibodies Monoclonalmedicine.diseasePrognosisImmunohistochemistrySurvival Analysismedicine.anatomical_structureOncologyMutationCancer researchbiology.proteinImmunohistochemistryRegression AnalysisFemaleAntibodyTumor Suppressor Protein p53Breast carcinomabusinessCell DivisionGynecologic oncology
researchProduct

Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation

2020

Abstract Primary meningeal melanocytomas are rare tumors of the central nervous system. Although they are considered benign neoplasms, some reports describe recurrent rates up to 45%. Little is known about their genetic and epigenetic landscape because of their infrequency. Even less has been described about markers with prognostic value. Here we describe a patient who developed a primary meningeal melanocytoma, suffered 3 recurrences in a period of 6 years and died of the tumor. The genetic and epigenetic changes explored confirmed GNAQ mutation as an initiating event. We found an epigenetic alteration of GSTP1, a feature that has recently been described in meningiomas, from the beginning …

Pathologymedicine.medical_specialtyMitotic indexProliferation indexDiseasePathology and Forensic MedicineMeningiomaLoss of heterozygosity03 medical and health sciencesCellular and Molecular NeuroscienceFatal Outcome0302 clinical medicineMeningeal NeoplasmsmedicineHumansEpigeneticsMelanomaCell ProliferationBRCA1 Proteinbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseGlutathione S-Transferase piNeurology030220 oncology & carcinogenesisMutationGTP-Binding Protein alpha Subunits Gq-G11FemaleNeurology (clinical)Neoplasm Recurrence LocalMelanocytomabusiness030217 neurology & neurosurgeryGNAQJournal of Neuropathology & Experimental Neurology
researchProduct

Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles

2009

Pathologymedicine.medical_specialtyMutationHistologyGeneral MedicineIn situ hybridizationBiologymedicine.disease_causePathology and Forensic MedicineAnaplastic EpendymomaGene expression profilingGene expressionmedicinemedicine.symptomGeneAnaplasiaHistopathology
researchProduct

Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain

1999

The incidence of p53 gene abnormalities in human hepatocellular carcinoma (HCC) varies in different geographical areas, being higher in regions where hepatitis virus infection and dietary exposure to aflatoxin B1 are the most common aetiological agents. These mutations are less frequently encountered in Europe, although some studies have reported p53 protein overexpression in up to 45% of cases analysed. We have analysed 129 tumour samples of primary malignant hepatic neoplasms recovered from paraffin blocks processed in two pathology laboratories in a Mediterranean area of Spain (Valencia and Gerona). Among 14 cases in which p53 immunohistochemistry expression proved positive, 5 stained in…

Pathologymedicine.medical_specialtyMutationTumor suppressor geneIncidence (epidemiology)Cell BiologyGeneral MedicineGene mutationBiologymedicine.diseasemedicine.disease_causePathology and Forensic MedicineMalignant transformationExonHepatocellular carcinomamedicineMolecular BiologyGeneVirchows Archiv
researchProduct

Genetic disorders of connective tissues

1991

Due to the growing knowledge of structure and function of extracellular matrix proteins, congenital abnormalities of connective tissues are identified or suspected in an increasing number of clinical disorders. In osteogenesis imperfecta and two subtypes of Ehlers-Danlos syndrome, the affected matrix proteins were identified and mutations in the corresponding genes (procollagen type I and type III, respectively) could be demonstrated. Some forms of chondrodysplasia were shown to be associated with mutations in the gene encoding for the cartilage-specific collagen (type II). In part, the clinical phenotype is determined by the tissue-specific distribution of these collagens. However, the cor…

Pathologymedicine.medical_specialtyMutationbusiness.industryOsteoarthritisOsteogenesis ImperfectaMatrix (biology)medicine.disease_causemedicine.diseaseProcollagen Type IPhenotypeExtracellular matrixPhenotypeRheumatologyOsteogenesis imperfectaMutationmedicineHumansCollagenConnective Tissue DiseasesbusinessGeneCurrent Opinion in Rheumatology
researchProduct

Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome

2021

6 páginas, 2 figuras

Pathologymedicine.medical_specialtyNeurosciences. Biological psychiatry. NeuropsychiatryDiseasePSEN1 mutationPresenilinCellular and Molecular NeuroscienceCerebrospinal fluidPSEN1MedicineFamily historyAmyotrophic lateral sclerosisMolecular BiologyPrimary Lateral Sclerosisbusiness.industryUpper motor neuronBrief Research ReportAlzheimer's diseasemedicine.diseasemedicine.anatomical_structuremotor neuron diseaseprimary lateral sclerosisprogressive spastic paraparesisbusinessAlzheimer’s diseaseNeuroscienceRC321-571
researchProduct

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.

2021

Purpose To characterise peritumoral zones in glioblastoma and anaplastic astrocytoma evaluating T2 values using T2 mapping sequences. Materials and methods In this study, 41 patients with histopathologically confirmed World Health Organization high grade gliomas and preoperative magnetic resonance imaging examinations were retrospectively identified and enrolled. High grade gliomas were differentiated: (a) by grade, glioblastoma versus anaplastic astrocytoma; and (b) by isocitrate dehydrogenase mutational state, mutated versus wildtype. T2 map relaxation times were assessed from the tumour centre to peritumoral zones by means of a region of interest and calculated pixelwise by using a fit m…

Pathologymedicine.medical_specialtyT2 mappingmultiparametric imagingAstrocytoma03 medical and health sciencesT2 mapping0302 clinical medicineGliomagliomamedicineHumansRadiology Nuclear Medicine and imagingneoplasmsRetrospective Studiesbusiness.industryBrain NeoplasmsMRI (magnetic resonance imaging)General MedicineOriginal Articlesmedicine.diseaseMagnetic Resonance ImagingIsocitrate DehydrogenaseMRI - Magnetic resonance imagingnervous system diseases030220 oncology & carcinogenesisMutationNeurology (clinical)businessGlioblastomaInfiltration (medical)030217 neurology & neurosurgeryGlioblastomaAnaplastic astrocytomaThe neuroradiology journal
researchProduct

Clinical spectrum of BICD2 mutations.

2020

Background and purpose Mutations in the BICD2 gene cause autosomal dominant lower extremity-predominant spinal muscular atrophy 2A (SMALED2A), a condition that is associated with a specific pattern of thigh and calf muscle involvement when studied by magnetic resonance imaging (MRI). Patients may present minor clinical sensory impairment, but objective sensory involvement has yet to be demonstrated. Methods We collected clinical data from 11 patients from five different families carrying mutations in BICD2. Genetic diagnosis was achieved using gene panel testing and skin biopsies were taken from two patients to study the epidermal nerve fiber density. Results In the studied patients, three …

Pathologymedicine.medical_specialtyWeaknessSensory systemNerve fiberBICD2 Charcot-Marie-Tooth hereditary motor neuropathy muscle magnetic resonance imaging spinal muscular atrophyThighmedicine.disease_causeMuscular Atrophy Spinal03 medical and health sciences0302 clinical medicineCharcot-Marie-Tooth DiseasemedicineHumans030212 general & internal medicineMuscle SkeletalMutationLegmedicine.diagnostic_testbiologybusiness.industryMagnetic resonance imagingSpinal muscular atrophymedicine.diseasebiology.organism_classificationMagnetic Resonance ImagingMediusmedicine.anatomical_structureNeurologyMutationNeurology (clinical)medicine.symptombusinessMicrotubule-Associated Proteins030217 neurology & neurosurgery
researchProduct

Familial Left Ventricular Noncompaction Associated With a Novel Mutation in the Alpha-cardiac Actin Gene

2014

Pathologymedicine.medical_specialtybusiness.industrymedicineLeft ventricular noncompactionGeneral MedicinebusinessGeneNovel mutationAlpha-Cardiac ActinRevista Española de Cardiología (English Edition)
researchProduct